10.88 USD
-0.25 (-2.25%)
10.95 USD
+0.07 (+0.64%)
We assign a fundamental rating of 4 out of 10 to IART. IART was compared to 184 industry peers in the Health Care Equipment & Supplies industry. IART has a medium profitability rating, but doesn't score so well on its financial health evaluation. IART has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year IART was profitable.
- IART had a positive operating cash flow in the past year.
- IART had positive earnings in 4 of the past 5 years.
- In the past 5 years IART always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of -13.58%, IART is in line with its industry, outperforming 58.70% of the companies in the same industry.
- IART has a Return On Equity of -47.74%. This is comparable to the rest of the industry: IART outperforms 51.63% of its industry peers.
- IART's Return On Invested Capital of 4.27% is fine compared to the rest of the industry. IART outperforms 74.46% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for IART is below the industry average of 8.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.58% | ||
| ROE | -47.74% | ||
| ROIC | 4.27% |
ROA(3y)2.09%
ROA(5y)2.89%
ROE(3y)4.61%
ROE(5y)6.54%
ROIC(3y)6.1%
ROIC(5y)6.15%
1.3 Margins
- Looking at the Operating Margin, with a value of 10.22%, IART is in the better half of the industry, outperforming 78.80% of the companies in the same industry.
- IART's Operating Margin has declined in the last couple of years.
- IART's Gross Margin of 57.21% is in line compared to the rest of the industry. IART outperforms 57.07% of its industry peers.
- IART's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.22% | ||
| PM (TTM) | N/A | ||
| GM | 57.21% |
OM growth 3Y-14.31%
OM growth 5Y-7.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.66%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IART is destroying value.
- Compared to 1 year ago, IART has less shares outstanding
- IART has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for IART is higher compared to a year ago.
2.2 Solvency
- IART has an Altman-Z score of 1.22. This is a bad value and indicates that IART is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of IART (1.22) is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.73 is on the high side and indicates that IART has dependencies on debt financing.
- The Debt to Equity ratio of IART (1.73) is worse than 79.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.22 |
ROIC/WACC0.57
WACC7.53%
2.3 Liquidity
- IART has a Current Ratio of 3.14. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.
- IART's Current ratio of 3.14 is in line compared to the rest of the industry. IART outperforms 58.70% of its industry peers.
- A Quick Ratio of 1.80 indicates that IART should not have too much problems paying its short term obligations.
- The Quick ratio of IART (1.80) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
- IART shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.44%.
- Measured over the past years, IART shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.35% on average per year.
- The Revenue has been growing slightly by 4.99% in the past year.
- Measured over the past years, IART shows a small growth in Revenue. The Revenue has been growing by 1.20% on average per year.
EPS 1Y (TTM)-4.44%
EPS 3Y-6.97%
EPS 5Y-1.35%
EPS Q2Q%31.71%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y1.45%
Revenue growth 5Y1.2%
Sales Q2Q%5.57%
3.2 Future
- Based on estimates for the next years, IART will show a small growth in Earnings Per Share. The EPS will grow by 2.68% on average per year.
- IART is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.39% yearly.
EPS Next Y-12.33%
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
EPS Next 5Y2.68%
Revenue Next Year1.09%
Revenue Next 2Y1.9%
Revenue Next 3Y2.45%
Revenue Next 5Y2.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 4.59 indicates a rather cheap valuation of IART.
- 98.91% of the companies in the same industry are more expensive than IART, based on the Price/Earnings ratio.
- IART is valuated cheaply when we compare the Price/Earnings ratio to 28.60, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 4.54 indicates a rather cheap valuation of IART.
- Based on the Price/Forward Earnings ratio, IART is valued cheaper than 99.46% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of IART to the average of the S&P500 Index (25.83), we can say IART is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.59 | ||
| Fwd PE | 4.54 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IART is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.45 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.22%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
- IART does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTEGRA LIFESCIENCES HOLDING / IART FAQ
Can you provide the ChartMill fundamental rating for INTEGRA LIFESCIENCES HOLDING?
ChartMill assigns a fundamental rating of 4 / 10 to IART.
What is the valuation status for IART stock?
ChartMill assigns a valuation rating of 6 / 10 to INTEGRA LIFESCIENCES HOLDING (IART). This can be considered as Fairly Valued.
What is the profitability of IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) has a profitability rating of 4 / 10.
What is the financial health of INTEGRA LIFESCIENCES HOLDING (IART) stock?
The financial health rating of INTEGRA LIFESCIENCES HOLDING (IART) is 3 / 10.